SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 102 filers reported holding SCICLONE PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $241,349,000 | +94.2% | 21,549 | +90.7% | 0.00% | – |
Q2 2017 | $124,267,000 | +12.2% | 11,297 | 0.0% | 0.00% | – |
Q1 2017 | $110,711,000 | +90646.7% | 11,297 | 0.0% | 0.00% | – |
Q4 2016 | $122,000 | -65.0% | 11,297 | -66.9% | 0.00% | – |
Q3 2016 | $349,000 | -21.6% | 34,097 | 0.0% | 0.00% | -100.0% |
Q2 2016 | $445,000 | +18.7% | 34,097 | 0.0% | 0.00% | – |
Q1 2016 | $375,000 | +10.0% | 34,097 | -8.1% | 0.00% | – |
Q4 2015 | $341,000 | +32.7% | 37,097 | 0.0% | 0.00% | – |
Q3 2015 | $257,000 | -29.4% | 37,097 | 0.0% | 0.00% | – |
Q2 2015 | $364,000 | +35.8% | 37,097 | +22.4% | 0.00% | – |
Q1 2015 | $268,000 | +4.7% | 30,297 | +3.8% | 0.00% | – |
Q4 2014 | $256,000 | +42.2% | 29,197 | +11.5% | 0.00% | – |
Q3 2014 | $180,000 | +30.4% | 26,197 | 0.0% | 0.00% | – |
Q2 2014 | $138,000 | +16.0% | 26,197 | 0.0% | 0.00% | – |
Q1 2014 | $119,000 | -9.8% | 26,197 | 0.0% | 0.00% | – |
Q4 2013 | $132,000 | -0.8% | 26,197 | 0.0% | 0.00% | – |
Q3 2013 | $133,000 | +2.3% | 26,197 | 0.0% | 0.00% | – |
Q2 2013 | $130,000 | – | 26,197 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athos Capital Ltd | 410,389 | $4,596,000 | 3.46% |
GLG Partners LP | 2,586,437 | $28,968,000 | 1.54% |
Nine Chapters Capital Management LLC | 32,300 | $362,000 | 0.80% |
FNY Partners Fund LP | 335,900 | $3,762,000 | 0.64% |
MENTA CAPITAL LLC | 373,523 | $4,183,000 | 0.61% |
Yakira Capital Management, Inc. | 85,500 | $958,000 | 0.32% |
Sapphire Star Partners LP | 18,724 | $209,000 | 0.27% |
GAM Holding AG | 541,025 | $6,059,000 | 0.26% |
Bowling Portfolio Management LLC | 127,873 | $1,432,000 | 0.22% |
Kassirer Asset Management Corp | 15,000 | $168,000 | 0.16% |